Form 4: Alpha Cognition Director Equity Grant Disclosure

Sentiment:

Director Equity Grant


Director Bethany Sensenig received a grant of 5,489 restricted stock units and 6,991 stock options from Alpha Cognition Inc.

Summary

  • Director Bethany Sensenig was granted 5,489 restricted stock units (RSUs) on April 16, 2026.
  • The director also received 6,991 stock options with an exercise price of $6.65 per share.
  • Both the RSUs and the stock options are subject to a one-year vesting period from the date of grant.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation practices rather than a change in company strategy or financial health.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.
  • Standardized vesting schedule ensures retention and commitment to the company's future performance.

Negatives

  • Issuance of new equity instruments results in potential future dilution for existing shareholders.

Risks

  • Market volatility affecting the value of the granted options.
  • Potential for future dilution of share value upon the exercise of options and vesting of RSUs.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director compensation changes.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the biotechnology and pharmaceutical sectors to ensure board alignment with long-term strategic milestones.

Comparison to Industry Standards

  • The use of one-year vesting periods for director equity is consistent with standard practices for small-cap biotech firms.
  • The structure of combining RSUs and options is a common compensation mix to balance risk and reward for board members.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director CompensationGrant of equity to Director Bethany Sensenig.04/16/2026Standard alignment of director incentives with company performance.

Stakeholder Impact

  • Shareholders may experience minor dilution upon the eventual exercise of options and vesting of units.

Next Steps

  • Vesting of restricted stock units on April 16, 2027.
  • Vesting of stock options on April 16, 2027.

Key Dates

DateDescription
04/16/2026Date of grant for restricted stock units and stock options.
04/16/2036Expiration date for the granted stock options.
04/17/2026Date of filing for the Form 4.

Keywords

Alpha Cognition, ACOG, Form 4, Insider Trading, Equity Compensation, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.